Bioheart's President/CEO Mike Tomas Inducted Into Miami Dade College Hall of Fame

Bioheart's President/CEO Mike Tomas Inducted Into Miami Dade College Hall of
Fame

SUNRISE, Fla., May 3, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB)
announced today that Mike Tomas, the company's President/CEO, has been named a
2012 Hall of Famer by Miami Dade College (MDC). Tomas is one of 25 alumni
presented with its top recognition, and induction into the MDC's Alumni Hall
of Fame, whose honorees are many of the nation's premier entrepreneurs,
professionals, public servants, artists and other leaders.

"Our Hall of Fame honorees span a wide range of professions and
possibilities," said MDC President Dr. Eduardo J. Padrón. "Their success
inspires us with optimism for what future generations of Miami Dade College
students will achieve and reminds us of education's ability to alter
individual lives, families and communities."

Mike Tomas was appointed as Bioheart's President, CEO and a Director on June
19, 2010. For the past 11 years, Tomas served as President of The ASTRI Group,
an early stage private equity investment company in Florida with an investment
in Bioheart. In 2003, he joined Bioheart's Board of Directors as the
independent representative of The ASTRI Group. Prior to this, Tomas held
ascending executive positions including Chief Marketing Officer at Avantel, a
$1 billion dollar joint venture with MCI. He currently sits on the boards of
Perimeter Internetworking, Avisena and Total Home Health. He is also the
current chairman of the Global Entrepreneurship Center at Florida
International University and a founding coach/mentor at the University of
Miami's Launch Pad at the Toppel Center.Mike holds a Masters of Business
Administration from the University of Miami, a Bachelor degree from Florida
International University and an Associate degree from Miami Dade College.

Each year, new alumni who have attained great success and made significant
contributions in their fields are selected to join MDC's Hall of Fame's
prestigious ranks. The impressive inductees represent all spectrums of the
community, from health care and public service to communications and
engineering. Miami Dade College will honor some of its outstanding alumni at
the 10^th annual Hall of Fame Gala, being held May 10, 2012 at 6pm at the
Hilton Miami Downtown.

Today, more than 174,000 students attend Miami Dade College, a state-supported
college with eight campuses and numerous outreach centers. Miami Dade College
is one of the largest institutions of higher education in the United States
and one of the most highly regarded colleges in the nation. For more
information, visit www.mdc.edu.

About Bioheart, Inc.

Bioheart is committed to maintaining its leading position within the
cardiovascular sector of the cell technology industry delivering cell
therapies and biologics that help address congestive heart failure, lower limb
ischemia, chronic heart ischemia, acute myocardial infarctions and other
issues. Bioheart's goals are to cause damaged tissue to be regenerated, when
possible, and to improve a patient's quality of life and reduce health care
costs and hospitalizations.

Specific to biotechnology, Bioheart is focused on the discovery, development
and, subject to regulatory approval, commercialization of autologous cell
therapies for the treatment of chronic and acute heart damage and peripheral
vascular disease. Its leading product, MyoCell, is a clinical muscle-derived
cell therapy designed to populate regions of scar tissue within a patient's
heart with new living cells for the purpose of improving cardiac function in
chronic heart failure patients. For more information on Bioheart, visit
www.bioheartinc.com, or visit us on Facebook: Bioheart and Twitter
@BioheartInc. 

Forward-Looking Statements: Except for historical matters contained herein,
statements made in this press release are forward-looking statements. Without
limiting the generality of the foregoing, words such as "may," "will," "to,"
"plan," "expect," "believe," "anticipate," "intend," "could," "would,"
"estimate," or "continue" or the negative other variations thereof or
comparable terminology are intended to identify forward-looking statements.

Forward-looking statements involve known and unknown risks, uncertainties and
other factors which may cause our actual results, performance or achievements
to be materially different from any future results, performance or
achievements expressed or implied by the forward-looking statements. Also,
forward-looking statements represent our management's beliefs and assumptions
only as of the date hereof. Except as required by law, we assume no obligation
to update these forward-looking statements publicly, or to update the reasons
actual results could differ materially from those anticipated in these
forward-looking statements, even if new information becomes available in the
future.

The Company is subject to the risks and uncertainties described in its filings
with the Securities and Exchange Commission, including the section entitled
"Risk Factors" in its Annual Report on Form 10-K for the year ended December
31, 2010, and its Quarterly Report on Form 10-Q for the quarter ended December
31, 2011.

CONTACT: Jeanne A. Becker
         Becker Public Relations
         2506 Ponce de Leon Blvd.
         Coral Gables, FL 33134
         Telephone 305/444-2181 X 222
         Email: jbecker@beckerpublicrelations.com
 
Press spacebar to pause and continue. Press esc to stop.